AU2003217609A8 - Treatment of disease by inducing cell apoptosis - Google Patents

Treatment of disease by inducing cell apoptosis

Info

Publication number
AU2003217609A8
AU2003217609A8 AU2003217609A AU2003217609A AU2003217609A8 AU 2003217609 A8 AU2003217609 A8 AU 2003217609A8 AU 2003217609 A AU2003217609 A AU 2003217609A AU 2003217609 A AU2003217609 A AU 2003217609A AU 2003217609 A8 AU2003217609 A8 AU 2003217609A8
Authority
AU
Australia
Prior art keywords
disease
treatment
cell apoptosis
inducing cell
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003217609A
Other versions
AU2003217609A1 (en
Inventor
Martina Buck
Mario Chojkier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2003217609A1 publication Critical patent/AU2003217609A1/en
Publication of AU2003217609A8 publication Critical patent/AU2003217609A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
AU2003217609A 2002-02-21 2003-02-21 Treatment of disease by inducing cell apoptosis Abandoned AU2003217609A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35876402P 2002-02-21 2002-02-21
US60/358,764 2002-02-21
PCT/US2003/005141 WO2003072031A2 (en) 2002-02-21 2003-02-21 Treatment of disease by inducing cell apoptosis

Publications (2)

Publication Number Publication Date
AU2003217609A1 AU2003217609A1 (en) 2003-09-09
AU2003217609A8 true AU2003217609A8 (en) 2003-09-09

Family

ID=27765989

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003217609A Abandoned AU2003217609A1 (en) 2002-02-21 2003-02-21 Treatment of disease by inducing cell apoptosis

Country Status (3)

Country Link
CN (1) CN1678336A (en)
AU (1) AU2003217609A1 (en)
WO (1) WO2003072031A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2984769C (en) * 2015-05-12 2023-03-21 The Regents Of The University Of California Peptide treatment for inflammation and fibrosis

Also Published As

Publication number Publication date
WO2003072031A2 (en) 2003-09-04
CN1678336A (en) 2005-10-05
AU2003217609A1 (en) 2003-09-09
WO2003072031A3 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
IL166280A0 (en) Treatment of TNF? related disorders
GB0316912D0 (en) Therapeutic treatment
GB0320806D0 (en) Therapeutic treatment
EP1536834A4 (en) Design of chemokine analogs for the treatment of human diseases
HK1078784A1 (en) Therapeutic treatment
GB0320238D0 (en) Treatment of disease
GB0223367D0 (en) Therapeutic treatment
EP1675547A4 (en) Glucocerebroside treatment of disease
IL174595A0 (en) Glucocerebroside treatment of disease
AU2003223780A8 (en) Treatment for pompe disease
LT1496918T (en) Use of sodium meta-arsenite for the treatment of tumours
AP2004003174A0 (en) Treatment of water
GB0210464D0 (en) Therapeutic treatment
GB0329275D0 (en) Therapeutic treatment
GB0307863D0 (en) Therapeutic treatment
AU2003217609A8 (en) Treatment of disease by inducing cell apoptosis
GB0313772D0 (en) Therapeutic treatment
AU2002241776A1 (en) Treatment of disease by inducing cell apoptosis
AU2002245331A1 (en) Treatment of disease by inducing cell apoptosis
GB0208194D0 (en) Treatment of disease
HU0302933D0 (en) Treatment of diseases
AU2003260820A8 (en) Nephritis treatment by gene therapy
GB0207139D0 (en) Novel therapeutic treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase